Steven L. Carroll

Steven L. Carroll

Auto-generated profile, based on publicly available information

Steven L. Carroll

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ANAdam C Naj
Adam C Naj
GJGyungah Jun
Gyungah Jun
GBGary W Beecham
Gary W Beecham
LWLi-San Wang
Li-San Wang
BVBadri Narayan Vardarajan
Badri Narayan Vardarajan
GSGerard D Schellenberg
Gerard D Schellenberg
Gerard Schellenberg and colleagues report a genome-wide association study of late-onset Alzheimer's disease (LOAD), as part of the Alzheimer Disease Genetics Consortium. They identify common variants in MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 associated with LOAD. The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1) and two replication stages (stages 2 and 3). Both joint analysis and meta-analysis approaches were used. We obtained genome-wide significant results at MS4A4A (rs4938933; stages 1 and 2, meta-analysis P (PM) = 1.7 × 10−9, joint analysis P (PJ) = 1.7 × 10−9; stages 1, 2 and 3, PM = 8.2 × 10−12), CD2AP (rs9349407; stages 1, 2 and 3, PM = 8.6 × 10−9), EPHA1 (rs11767557; stages 1, 2 and 3, PM = 6.0 × 10−10) and CD33 (rs3865444; stages 1, 2 and 3, PM = 1.6 × 10−9). We also replicated previous associations at CR1 (rs6701713; PM = 4.6 × 10−10, PJ = 5.2 × 10−11), CLU (rs1532278; PM = 8.3 × 10−8, PJ = 1.9 × 10−8), BIN1 (rs7561528; PM = 4.0 × 10−14, PJ = 5.2 × 10−14) and PICALM (rs561655; PM = 7.0 × 10−11, PJ = 1.0 × 10−10), but not at EXOC3L2, to late-onset Alzheimer's disease susceptibility1,2,3.

14 February 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VDVivianna M Van Deerlin
Vivianna M Van Deerlin
PSPatrick M A Sleiman
Patrick M A Sleiman
MMMaria Martinez-Lage
Maria Martinez-Lage
ACAlice Chen-Plotkin
Alice Chen-Plotkin
LWLi-San Wang
Li-San Wang
VLVirginia M-Y Lee
Virginia M-Y Lee
Vivianna Van Deerlin and colleagues report that common variants at 7p21 are associated with a subtype of frontotemporal lobar degeneration marked by TDP-43 inclusions. They further show that the risk alleles are associated with elevated brain expression of TMEM106B, which resides at the peak of association on 7p21. Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP)1. FTLD-TDP is frequently familial, resulting from mutations in GRN (which encodes progranulin). We assembled an international collaboration to identify susceptibility loci for FTLD-TDP through a genome-wide association study of 515 individuals with FTLD-TDP. We found that FTLD-TDP associates with multiple SNPs mapping to a single linkage disequilibrium block on 7p21 that contains TMEM106B. Three SNPs retained genome-wide significance following Bonferroni correction (top SNP rs1990622, P = 1.08 × 10−11; odds ratio, minor allele (C) 0.61, 95% CI 0.53–0.71). The association replicated in 89 FTLD-TDP cases (rs1990622; P = 2 × 10−4). TMEM106B variants may confer risk of FTLD-TDP by increasing TMEM106B expression. TMEM106B variants also contribute to genetic risk for FTLD-TDP in individuals with mutations in GRN. Our data implicate variants in TMEM106B as a strong risk factor for FTLD-TDP, suggesting an underlying pathogenic mechanism.

1 March 1997 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SCSteven L. Carroll
Steven L. Carroll
MMMichele L. Miller
Michele L. Miller
PFPaul W. Frohnert
Paul W. Frohnert
SKSusanne S. Kim
Susanne S. Kim
JCJohn A. Corbett
John A. Corbett
Schwann cell dedifferentiation and proliferation is a prerequisite to axonal regeneration in the injured peripheral nervous system. The neuregulin (NRG) family of growth and differentiation factors may play a particularly important role in this process, because these axon-associated molecules are potent Schwann cell mitogens and differentiation factorsin vitro. We have examined Schwann cell DNA synthesis and the expression of NRGs and their receptors, the erbB membrane tyrosine kinases, in rat sciatic nerve, sensory ganglia, and spinal cord 0–30 d postaxotomy. Analysis of NRG cDNAs from these tissues revealed several novel splice variants and showed that cells endogenous to injured nerve express NRG mRNAs. A selective induction of mRNAs encoding the glial growth factor (GGF) subfamily of NRGs occurs in nerve beginning 3 d postaxotomy and thus coincides with the onset of Schwann cell DNA synthesis. In later stages of Wallerian degeneration, however, Schwann cell mitogenesis markedly decreases, whereas elevated GGF expression persists. Of the four known erbB kinases, Schwann cells express both erbB2 and erbB3 receptors over the entire interval studied. Expression of erbB2 and erbB3 is coordinately induced in response to axotomy, indicating that Schwann cell responses to NRGs may be modulated by changes in receptor density. Neuregulin (including transmembrane precursors) and erbB protein are associated with Schwann cells postaxotomy. Thus, in contrast to the concept of NRGs as axon-associated mitogens, our findings suggest that NRGs produced by Schwann cells themselves may be partially responsible for Schwann cell proliferation during Wallerian degeneration, probably acting via autocrine or paracrine mechanisms.

1 December 2004 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
KGKimberly M. Gerecke
Kimberly M. Gerecke
JWJ. Michael Wyss
J. Michael Wyss
SCSteven L. Carroll
Steven L. Carroll

1 January 2003 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
ACAbhik Ray Chaudhury
Abhik Ray Chaudhury
KGKimberly M. Gerecke
Kimberly M. Gerecke
JWJ. Michael Wyss
J. Michael Wyss
DMDavid G. Morgan
David G. Morgan
MGMarcia N. Gordon
Marcia N. Gordon
SCSteven L. Carroll
Steven L. Carroll
Neuregulin-1 (NRG-1) regulates developmental neuronal survival and synaptogenesis, astrocytic differentiation, and microglial activation. Given these NRG-1 actions, we hypothesized that the synaptic loss, gliosis, inflammation, and neuronal death occurring in Alzheimer disease (AD) is associated with altered expression of NRG-1 and its receptors (the erbB2, erbB3, and erbB4 membrane tyrosine kinases). We examined the expression and distribution of NRG-1 and the erbB kinases in the hippocampus of AD patients and cognitively normal controls and in transgenic mice that coexpress AD-associated mutations of the β amyloid precursor protein (APPK670N,M671L) and presenilin-1 (PS1M146L). In the hippocampi of both control humans and wild type mice, NRG-1 and the 3 erbB receptors are expressed in distinct cellular compartments of hippocampal neurons. All 4 molecules are associated with neuronal cell bodies, but only NRG-1, erbB2, and erbB4 are present in synapse-rich regions. In AD and in the doubly transgenic mouse, erbB4 is expressed by reactive astrocytes and microglia surrounding neuritic plaques. In AD brains, microglia and, to a lesser extent, dystrophic neurites, also upregulate NRG-1 in neuritic plaques, suggesting that autocrine and/or paracrine interactions regulate NRG-1 action within these lesions. NRG-1 and erbB4, as well as erbB2, are similarly associated with neuritic plaques in the doubly transgenic mice. Thus, in AD the hippocampal distribution of NRG-1 and erbB4 is altered. The similarities between the alterations in the expression of NRG-1 and its receptors in human AD and in APPK670N;M671L/PS1M146L mutant mice suggests that this animal model may be very informative in deciphering the potential role of these molecules in AD.

20 March 2001 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
KGKimberly M. Gerecke
Kimberly M. Gerecke
JWJ. Michael Wyss
J. Michael Wyss
IKIrina Karavanova
Irina Karavanova
ABAndres Buonanno
Andres Buonanno
SCSteven L. Carroll
Steven L. Carroll